Teresa Lavenue has helped clients in many different industry sectors to build robust patent portfolios. With more than 20 years of technical and legal experience, Teresa successfully represents U.S. and foreign clients, including individual inventors, emerging companies, universities, and Fortune 500 companies, in the procurement, management, and development of intellectual property rights.
Teresa has written or prosecuted over 600 patent applications in the biotech field covering a vast array of technologies, such as pharmacology, pharmaceuticals, nutraceuticals, immunology, and cancer therapy. She has also handled applications related to siRNA and antisense inhibition, inflammation, carbon nanotubes, liposomes, DNA/RNA purification and protein arrays, and cancer biomarkers, as well as synthetic bio-molecules, transgenic plants, medical devices, plant culture, insecticides, therapeutic plant extracts. In addition to her experience in the life sciences, Teresa has drafted and/or prosecuted patents in numerous other fields, including liquid crystal display polymers, printers, scanners, inks, food science, shrink films, and photovoltaic cells.
Teresa has also conducted due diligence for major corporate transactions, performed numerous freedom-to-operate analyses, and prepared invalidity and non-infringement opinions to assist clients in bringing their products to market, free of meritorious infringement claims by others.
After graduating from American University, Washington College of Law, Teresa served as a law clerk for The Honorable Glenn Archer, Chief Judge of the U.S. Court of Appeals for the Federal Circuit. Prior to beginning her legal career, Teresa performed scientific research for seven years at Vanderbilt University (Department of Molecular Physiology and Biophysics) and Georgetown University (Division of Molecular Virology and Immunology).
Areas of Focus
Represented medical device company in patent prosecution for their spinal implant device.
Represented a large chemical company in patent prosecution of liquid crystal display polymers.
Represent a life sciences "think tank" in the patent prosecution of various biotech patents.